Budenofil 3 Tablet CR

$11.48

1 Strip, 10 tablet cr per strip

Active ingredient: Budesonide (3mg)

Out of stock

Free worldwide shipping on all orders over $50

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

Budenofil 3 Tablet CR from our pharmacy
Budenofil 3 Tablet CR
$11.48

Introduction

Budenofil is a prescription medication that contains the active ingredient Budesonide. It is available in tablet form and is commonly prescribed under the brand name Budenofil. This medication belongs to a class of drugs known as corticosteroids and is primarily used for its anti-inflammatory properties.

Uses

Budenofil is prescribed for the treatment of various inflammatory conditions, particularly those affecting the gastrointestinal tract. It is commonly used to manage symptoms associated with Crohn’s disease and ulcerative colitis, both of which are chronic inflammatory bowel diseases. This medication helps to reduce inflammation, relieve symptoms, and promote healing in the affected areas.

Dosage and Administration

The dosage of Budenofil will vary depending on the specific condition being treated and the individual patient. Follow the instructions provided by your healthcare professional. Generally, the recommended starting dose for adults is 9 mg per day, divided into two or three smaller doses. This dosage may be adjusted based on the response to treatment and any side effects experienced. The tablets should be taken orally with a glass of water and can be taken with or without food.

Mechanism of Action

Budesonide, the active ingredient in Budenofil, works by reducing inflammation in the body. It acts locally in the gastrointestinal tract, where it helps to suppress the immune response that leads to inflammation. By doing so, it helps to alleviate the symptoms associated with inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis. Budesonide has a high affinity for glucocorticoid receptors, which are present in the cells of the intestinal mucosa. This allows it to exert its anti-inflammatory effects directly at the site of inflammation.

Side Effects

Common side effects may include headache, dizziness, nausea, abdominal pain, and changes in appetite. These side effects are generally mild and may resolve on their own. However, if any of these side effects persist or worsen. Consult your healthcare professional.

In some cases, Budenofil may cause more serious side effects. These can include increased susceptibility to infections, mood changes, vision problems, and signs of adrenal suppression (such as fatigue and weight loss). If you experience any of these serious side effects, seek medical attention immediately.

Drug Interactions

Budenofil may interact with other medications, including certain antifungals, antibiotics, and HIV protease inhibitors. Inform your healthcare professional about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. They can help determine if any potential drug interactions may occur and adjust your treatment plan accordingly.

Precautions

Before starting treatment with Budenofil, inform your healthcare professional about any allergies, medical conditions, and medications you are currently taking. This medication should be used with caution in patients with a history of liver disease, as it may affect liver function.

Budenofil should not be used in patients with known hypersensitivity to budesonide or any of the other ingredients in the formulation. It is also contraindicated in patients with active or untreated infections, as it may suppress the immune system.

Storage

Budenofil should be stored at room temperature, away from moisture and heat. Keep the medication in its original packaging and out of reach of children.

Patient Tips

  • Take Budenofil exactly as prescribed by your healthcare professional. Do not exceed the recommended dosage or change the dosing schedule without consulting them.
  • If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
  • attend regular follow-up appointments with your healthcare professional to monitor your response to treatment and any potential side effects.
  • If you experience any signs of infection such as fever, sore throat, or persistent cough, contact your healthcare professional immediately.
  • Do not stop taking Budenofil abruptly without consulting your healthcare professional, as this may lead to a worsening of symptoms. They will provide guidance on how to safely discontinue the medication if needed.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

  • Budesonide tablets, capsules and granules: steroid to treat inflammation (NHS UK) [Accessed 26 Jun. 2024] (online) Available at:
  • Benacort 64 micrograms Nasal Spray (Health Professionals SmPC) Available at:
  • Budesonide (Drugs.com) [Accessed 6 Jun. 2024] (online) Available at:
  • albuterol 90 mcg-budesonide 80 mcg/actuation hfa aerosol inhaler (RX) [Accessed 23 Jun. 2024] (online) Available at:
  • Budesonide (MedlinePlus) [Accessed 28 Jun. 2024] (online) Available at:
  • López-Sanromán A, Clofent J, Garcia-Planella E, Menchén L, Nos P, Rodríguez-Lago I, Domènech E. Reviewing the therapeutic role of budesonide in Crohn’s disease. Gastroenterol Hepatol. 2018 Aug-Sep;41(7):458-471. doi: 10.1016/j.gastrohep.2018.05.013. Epub 2018 Jul 12. [Accessed 3 Jun. 2024] Available at:

Additional information

Active ingredients

Strength

Budesonide (3mg)

Indications

Ulcerative colitis

Brand

Manufacturer

Manufacturer's location

#1, Fourrts Avenue, Annai Indira Nagar, Okkiyam Thoraipakkam, Chennai, India

Reviews

There are no reviews yet.

Be the first to review “Budenofil 3 Tablet CR”

Your email address will not be published. Required fields are marked *